IICT, a constituent lab of CSIR, and Lee Pharma, an integrated pharma company, based in Hyderabad have entered into a non-exclusive licensing agreement for the synthesis of 2-DG.
2-DG developed by DRDO and Dr. Reddy’s Lab. has received approval for use in Covid-19 patients pic.twitter.com/R4xaFfsJjR— Prasar Bharati News Services पी.बी.एन.एस. (@PBNS_India) June 9, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


